Search

Results for 'clinic'

Clear
Narrow Results
Search
Use my current location
Search

Affiliations Collapsed

Language Collapsed

Gender Collapsed

    Narrow search results by selecting an item from the filters below. Use tab and enter keyboard keys to select / unselect an item
  • Female (25)
  • Male (16)

Location Type Collapsed

Event Month Collapsed

City Collapsed

Service Type Collapsed

    Narrow search results by selecting an item from the filters below. Use tab and enter keyboard keys to select / unselect an item
  • Care Area (50)
  • Treatment (10)

Cost Collapsed

    Narrow search results by selecting an item from the filters below. Use tab and enter keyboard keys to select / unselect an item
  • Free (50)

Event Category Collapsed

Tag Collapsed

Number of results found: 742
Use this additional navigation to go to the next pages. Use tab and enter keyboard keys to navigate the menu Navigate to previous page Page # 4 Page # 5 Page # 6 7 Page # 8 Page # 9 Page # 10 Navigate to next page Page 7 of 62
Skipped to 742 results found. Page 7 of 62
  • Cancer Treatment

    Cancer Treatment Cancer treatment at the William N. Pennington Cancer Institute includes advanced options ranging from chemotherapy and radiation to surgery and clinical trials.

    Read More About Cancer Treatment

  • Breast Surgical Oncology

    Breast Surgery Care at Renown Health Renown Breast Surgery Care, located within the Center for Advanced Medicine B, is a comprehensive, fully integrated breast surgery clinic, addressing a wide spectrum of breast problems ranging from benign to cancerous: Benign breast conditions such as fibroadenoma, phyllodes tumors, and nipple discharge Breast cancer risk assessment and genetics High risk breast lesions such as atypical ductal hyperplasia, atypical lobular hyperplasia, LCIS, papillary lesions, and radial scars Advanced breast cancer surgical techniques including oncoplastic surgery for best aesthetic outcomes possible and nipple sparing mastectomies, working closely with skilled plastic reconstructive surgeons. Our highly experienced breast surgical oncologists are continuing to expand our team to better meet the evolving needs of our community and beyond.  We are excited to soon be incorporating an oncology wellness team who can further support our patients with focused nutritional guidance, functional assessments for prehabilitation needs prior to surgery or medical treatments, and guidance for development of physical activity and other exercise programs, for best outcomes in cancer treatment as well as future risk reduction. The National Accreditation Program for Breast Centers (NAPBC) is a rigorous process designed to ensure high quality care for breast centers by meeting thoughtfully created standards that are constantly being reviewed and updated for ongoing improvement of patient care. We are the only NAPBC-accredited program in Northern Nevada.

    Read More About Breast Surgical Oncology

  • Histotripsy

    Renown’s Surgical Oncology team are amongst the first to use HistoSonic Edison® Liver Ablation system, a revolutionary advancement that leverages focused ultrasound to provide non-invasive, precise and efficient treatment solutions, thanks to a private donation.   This state-of-the-art solution for liver tumor ablation requires no incisions or introducers into the body by using focused ultrasound waves to noninvasively destroy a designated tissue or tumor in the liver, providing leading-edge surgical care to patients. Renown joins the Cleveland Clinic, Mayo Clinic and Johns Hopkins in being amongst the first in the country to offer this revolutionary non-invasive clinical procedure.

    Read More About Histotripsy

    Battling Pediatric Cancer Together: Renown's COG Membership

    Every year, 16,000 children face the daunting diagnosis of cancer, and what might surprise you is that almost 90% of them receive treatment at institutions affiliated with the Children's Oncology Group (COG). Renown Children’s Hospital, a member of COG since 2020, plays a vital role in this transformative journey. Just half a century ago, childhood cancer was a near-incurable challenge, but today, thanks to the groundbreaking research led by COG, the survival rate over a five-year period has soared to an inspiring 80%. “The standard of care continues to advance, particularly with cancer, as more research is conducted and additional treatment options become available,” said Kristen Gurnea, Manager of Clinical Research at Renown Health. “Our community can contribute to these advancements through COG for the benefit of both individual patients and the entire population joined together in the fight against pediatric cancer. We are proud to contribute to that mission.” As a member of the world's largest organization devoted exclusively to childhood cancer research, Renown recognizes the joint efforts from researchers and patients alike and is proud to aid in reaching this goal in partnership with COG and our very own northern Nevada community.

    Read More About Battling Pediatric Cancer Together: Renown's COG Membership

    • Neurology
    • Research and Studies

    Multiple Sclerosis Research Opportunities in Northern Nevada

    There are nearly 1 million adults living with MS in the United States alone. For comparison, that is roughly the entire population of the Reno/Sparks and Las Vegas areas combined. MS is a neurological autoimmune condition which means that the immune system of patients with MS attacks the body’s myelin, a protective substance that covers your nerves. When this happens, the unprotected nerves can be damaged. Patients with MS may experience many different symptoms ranging from mild to severe, such as mobility and vision problems, fatigue and difficulty thinking. MS is usually diagnosed between the ages of 20-50, but late onset MS can occur in patients over 50 years old. While there is no cure for MS, there are effective treatments that can help reduce the burden of patients’ symptoms and create a positive quality of life. At Renown Health, we have joined the fight against MS through a partnership between advanced neurology programs and providers and our research office. We are proud to offer newly diagnosed MS patients the opportunity to choose between standard care treatment options or participating in an open label clinical trial, the AGNOS study. This study is assessing the impact of a new medication, ofatumumab, as the first disease modifying therapy participants receive for managing relapsing remitting MS, the most common form of MS.

    Read More About Multiple Sclerosis Research Opportunities in Northern Nevada

Number of results found: 742
Use this additional navigation to go to the next pages. Use tab and enter keyboard keys to navigate the menu Navigate to previous page Page # 4 Page # 5 Page # 6 7 Page # 8 Page # 9 Page # 10 Navigate to next page Page 7 of 62
Skipped to 742 results found. Page 7 of 62